DCK and acute myeloid leukemia: Patients with de novo AML and variant alleles of DCK c.-201C>T (rs2306744) and CDA c.-92A>G (rs602950) showed higher complete remission rates, along with lower survival rates for variant alleles of CDA c.79A>C (rs2072671), c.-31del (rs3215400) and wild-type genotype of c.-92A>G (rs602950) [32].